Sarsia

Sarsia is an early-stage venture capital firm investing in a greener and healthier future. They aim to create value by linking good solutions and science with competent capital, focusing on technologies that can improve the quality of life, society, and reduce negative impact on nature. They thrive on change and dare to take risks to create value, which has made them one of the best performing VC firms in the Nordic countries. Their approach involves being reliable and connecting founders with venture capital. They view every investment as a long-term commitment and provide startups with the security to develop at the right tempo, in accordance with the founder's vision. Sarsia creates a network for startup companies. Their experience and expertise allow a new and brilliant idea to make its way into society. Sarsia focuses on unmet medical needs, where competence and capital are decisive in turning laboratory results into effective treatments for patients. In the technology, energy, and sustainability sectors, they search for technologies and founders capable of accelerating the green transition and building sustainable companies for the future. They are motivated by making a difference and contributing to technologies that solve important challenges. Sarsia has been operating for 20 years, managing 1300m NOK across 3 funds. Their portfolio includes 29 companies and they state that they are a top-performing fund within Norwegian Early Stage Venture. The firm also claims to have backed two of the most valuable early-stage venture-backed companies in Norway.

Life Sciences, Technology, Energy, Sustainability, Clean Tech

Core thematic spaces, technologies, and target market segments of interest.